¼¼°èÀÇ °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀå : ½ÃÀå ±Ô¸ð ºÐ¼®(Á¦Ç°º°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°)°ú ¿¹Ãø(2022-2032³â)
Global Infectious Disease Molecular Diagnostics Market Size Study, By Product, By Technology, By Application, By End Use, and Regional Forecasts 2022-2032
»óǰÄÚµå : 1663373
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 285 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,967,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,796,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀåÀº 2023³â 520¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö ¿¹Ãø ±â°£ µ¿¾È 3.9%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

HIV/AIDS, °áÇÙ, °£¿°, È£Èí±â °¨¿° µî Àü ¼¼°è Áúº´ ºÎ´ãÀÇ Àå±âÈ­¿¡ µû¸¥ °¨¿°¼º ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±Þ°ÝÇÑ Áõ°¡´Â ½Ç¿ëÀûÀÎ °á°ú¸¦ °¡Á®¿Ã ¼ö ÀÖ´Â Á¤¹ÐÇÏ°í ½Å¼ÓÇÑ Áø´Ü ±â¼ú¿¡ ´ëÇÑ ½É°¢ÇÑ ¼ö¿ä¸¦ °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR), ÇÙ»êÁõÆø, Â÷¼¼´ë¿°±â¼­¿­ºÐ¼®(NGS)ÀÇ È¹±âÀûÀÎ ±â¼ú Çõ½ÅÀ» Ȱ¿ëÇÑ Ã·´Ü ºÐÀÚÁø´Ü¹ýÀº °ËÃâ Á¤È®µµ¸¦ ³ôÀÌ°í ´ëÀÀ ½Ã°£À» ´ÜÃàÇÏ¿© Áø´Ü ÆÐ·¯´ÙÀÓÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ÀÇ·á Àü¹®°¡µéÀÌ º´¿øÃ¼¸¦ ½Å¼ÓÇÏ°Ô ½Äº°Çϰí, ȯÀÚ ¿¹Èĸ¦ °³¼±Çϸç, È¿°úÀûÀÎ °øÁߺ¸°Ç ´ëÀÀÀ» ÃËÁøÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú R&D ÀÚ±ÝÀº ±â¼ú °³¹ßÀ» ´õ¿í ÃËÁøÇÏ¿© ¾÷°è°¡ °è¼Ó ÁøÈ­ÇÏ°í »õ·Î¿î Áø´Ü °úÁ¦¿¡ ´ëÀÀÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

¼¼°èÀûÀ¸·Î °í·ÉÈ­°¡ ÁøÇàµÊ¿¡ µû¶ó °í·ÉÀÚ´Â °¨¿° ¹× °ü·Ã ÇÕº´Áõ¿¡ Ãë¾àÇϱ⠶§¹®¿¡ Áø´Ü¾à¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¶±â ¹ß°ß ¹× Á¶±â Ä¡·á¸¦ À§ÇÑ Á¤ºÎ ÁÖµµÀÇ ³ë·ÂÀ¸·Î, ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ¸·´ëÇÑ ÅõÀÚ°¡ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä« µîÀÇ Áö¿ª¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶ó °³¼±°ú ÀÎ½Ä °³¼±À¸·Î Áø´Ü µµ±¸¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ °­È­µÇ¾î Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ±â¾÷µéÀº Áø´Ü ½Ã¾à, ¼­ºñ½º, ÀåºñÀÇ ÀμöÇÕº´(M&A)°ú ±â¼ú Çõ½ÅÀ» ÅëÇØ Àû±ØÀûÀ¸·Î Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ½Ã¾àÀº 2023³â 57.1%ÀÇ ¾ÐµµÀûÀÎ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» Àå¾ÇÇϰí ÀÖÀ¸¸ç, PCR¿¡¼­ PoC °Ë»ç±îÁö Áø´Ü ¿öÅ©Ç÷ο쿡 ÇʼöÀûÀÎ ½Ã¾àÀº ½ÃÀå ¸®´õ½ÊÀ» °ø°íÈ÷ Çϰí ÀÖ½À´Ï´Ù. ÇÑÆí, µðÁöÅÐ PCR ¹× ÀÚµ¿È­ Ç÷§Æû°ú °°Àº ±â¼ú Çõ½Å¿¡ ÈûÀÔÀº Áø´Ü ¼­ºñ½º´Â Áúº´ °ü¸®¸¦ À§ÇÑ Á¾ÇÕÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¸ç °¡Àå ºü¸¥ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ³ôÀº Áúº´ ÀÌȯÀ²°ú źźÇÑ ÀÇ·á½Ã½ºÅÛÀÌ ±× ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ôÀº °¨¿°¼º Áúȯ ºÎ´ã°ú ÀÇ·á ÅõÀÚ Áõ°¡·Î ÀÎÇØ ¿¬Æò±Õ 6.9%ÀÇ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀå : ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀå : Á¤ÀÇ¹× ºÐ¼® ÀüÁ¦

Á¦3Àå ¼¼°èÀÇ °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀå ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Á¦Ç°º°(2022-2032³â)

Á¦6Àå ¼¼°èÀÇ °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ±â¼úº°(2022-2032³â)

Á¦7Àå ¼¼°èÀÇ °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ¿ëµµº°(2022-2032³â)

Á¦8Àå ¼¼°èÀÇ °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2022-2032³â)

Á¦9Àå ¼¼°èÀÇ °¨¿°¼º Áúȯ ºÐÀÚÁø´Ü ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°(2022-2032³â)

Á¦10Àå °æÀï Á¤º¸

Á¦11Àå ºÐ¼® ÇÁ·Î¼¼½º

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global infectious disease molecular diagnostics market, valued at USD 52.0 billion in 2023, is anticipated to grow significantly at a compound annual growth rate (CAGR) of 3.9% during the forecast period of 2024 to 2032. The rising incidence of infectious diseases, driven by the persistent global burden of conditions like HIV/AIDS, tuberculosis, hepatitis, and respiratory infections, is a major factor propelling the market. This surge underscores the critical demand for precise, rapid diagnostic technologies capable of delivering actionable results.

Advanced molecular diagnostics, leveraging groundbreaking innovations in Polymerase Chain Reaction (PCR), nucleic acid amplification, and next-generation sequencing (NGS), have transformed diagnostic paradigms by enhancing detection accuracy and accelerating response times. These advances enable healthcare professionals to identify pathogens swiftly, improving patient outcomes and facilitating effective public health responses. Regulatory support and research funding have further catalyzed technological development, ensuring the industry continues to evolve and meet emerging diagnostic challenges.

Aging populations globally have amplified the demand for diagnostics, as older adults face heightened susceptibility to infections and related complications. Additionally, government-led initiatives promoting early detection and treatment have driven substantial investments in healthcare infrastructure, especially in emerging markets. Regions such as Asia Pacific and Latin America are experiencing significant growth due to enhanced access to diagnostic tools, bolstered by improved healthcare infrastructure and increased awareness.

Major market players are actively expanding their portfolios through mergers, acquisitions, and innovations in diagnostic reagents, services, and instrumentation. Reagents, in particular, dominated the market in 2023, holding a commanding 57.1% share. Their indispensability in diagnostic workflows, from PCR to PoC testing, has solidified their market leadership. Meanwhile, diagnostic services, driven by innovations like digital PCR and automated platforms, are projected to exhibit the fastest growth, offering comprehensive solutions for disease management.

Regionally, North America held the largest market share in 2023, fueled by high disease prevalence and robust healthcare systems. However, the Asia Pacific region is anticipated to lead the growth trajectory, with a projected CAGR of 6.9%, driven by its high infectious disease burden and increasing healthcare investments.

Major market players included in this report are:

The detailed segments and sub-segment of the market are explained below:

By Product:

By Technology:

By Application:

By End Use:

By Region:

Years considered for the study are as follows:

Key Takeaways:

Table of Contents

Chapter 1. Global Infectious Disease Molecular Diagnostics Market Executive Summary

Chapter 2. Global Infectious Disease Molecular Diagnostics Market Definition and Research Assumptions

Chapter 3. Global Infectious Disease Molecular Diagnostics Market Dynamics

Chapter 4. Global Infectious Disease Molecular Diagnostics Market Industry Analysis

Chapter 5. Global Infectious Disease Molecular Diagnostics Market Size & Forecast by Product 2022-2032

Chapter 6. Global Infectious Disease Molecular Diagnostics Market Size & Forecast by Technology 2022-2032

Chapter 7. Global Infectious Disease Molecular Diagnostics Market Size & Forecast by Application 2022-2032

Chapter 8. Global Infectious Disease Molecular Diagnostics Market Size & Forecast by End Use 2022-2032

Chapter 9. Global Infectious Disease Molecular Diagnostics Market Size & Forecast by Region 2022-2032

Chapter 10. Competitive Intelligence

Chapter 11. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â